Avantax Planning Partners, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.26 - $7.97 $652 - $988	-124 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$4.65 - $7.95 $576 - $985	124 New	124 $1,000
Q2 2018 Aug 13, 2018	SELL	$5.05 - $6.8 $626 - $843	-124 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $694 - $1,147	124 New	124 $1,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $724M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.